Literature DB >> 17564837

Pressure-related increase of asymmetric dimethylarginine caused by hyperbaric oxygen in the rat brain: a possible neuroprotective mechanism.

Emin Ozgür Akgül1, Erdinc Cakir, Omer Ozcan, Halil Yaman, Yasemin Gülcan Kurt, Sükrü Oter, Ahmet Korkmaz, Cumhur Bilgi, Mehmet Kemal Erbil.   

Abstract

A decrease in nitric oxide availability in the brain tissue due to the inhibition of nitric oxide synthase (NOS) activity during the early phases of hyperbaric oxygen (HBO) exposure was found to be involved in hyperoxic vasoconstriction leading to reduced regional cerebral blood flow. We hypothesized that the concentration of asymmetric dimethylarginine (ADMA), an endogenous inhibitor of nitric oxide synthase (NOS), may be an important factor during this hyperoxic vasoconstriction state. Rats were exposed to 1, 2 and 3 atmospheres pure oxygen for two hours. A fourth group of animals served as control. Asymmetric dimethylarginine, L-Arginine and nitrite/nitrate (NOx) concentrations were measured from deproteinized rat brain cytosols. In rat brains exposed to 3 atmospheres O2, ADMA and L-Arginine levels were found to be significantly higher and NOx significantly lower than control levels. Additionally, statistically significant correlations between ADMA and L-Arginine, and ADMA and NOx concentrations were detected. In conclusion, this is the first study indicating increased ADMA levels in rat brains exposed to HBO. The simultaneously decreased NOx values suggest that ADMA elevation resulted in NOS inhibition and therefore may be responsible for the early phase hyperoxic vasoconstriction.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17564837     DOI: 10.1007/s11064-007-9363-4

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  31 in total

Review 1.  NO news is good news.

Authors:  E Culotta; D E Koshland
Journal:  Science       Date:  1992-12-18       Impact factor: 47.728

2.  Role of cerebral blood flow in seizures from hyperbaric oxygen exposure.

Authors:  M Chavko; J C Braisted; N J Outsa; A L Harabin
Journal:  Brain Res       Date:  1998-04-27       Impact factor: 3.252

3.  Hyperbaric oxygen reduces cerebral blood flow by inactivating nitric oxide.

Authors:  I T Demchenko; A E Boso; P B Bennett; A R Whorton; C A Piantadosi
Journal:  Nitric Oxide       Date:  2000-12       Impact factor: 4.427

4.  Effect of hyperbaric oxygen treatment on nitric oxide and oxygen free radicals in rat brain.

Authors:  I M Elayan; M J Axley; P V Prasad; S T Ahlers; C R Auker
Journal:  J Neurophysiol       Date:  2000-04       Impact factor: 2.714

5.  NMDA-dependent superoxide production and neurotoxicity.

Authors:  M Lafon-Cazal; S Pietri; M Culcasi; J Bockaert
Journal:  Nature       Date:  1993-08-05       Impact factor: 49.962

6.  Hyperoxia increases H2O2 production by brain in vivo.

Authors:  T Yusa; J S Beckman; J D Crapo; B A Freeman
Journal:  J Appl Physiol (1985)       Date:  1987-07

7.  Relationship between protein nitration and oxidation and development of hyperoxic seizures.

Authors:  Mikulas Chavko; Charles R Auker; Richard M McCarron
Journal:  Nitric Oxide       Date:  2003-08       Impact factor: 4.427

8.  Extracellular superoxide dismutase, nitric oxide, and central nervous system O2 toxicity.

Authors:  T D Oury; Y S Ho; C A Piantadosi; J D Crapo
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-15       Impact factor: 11.205

9.  Activation of BDNF mRNA and protein after seizures in hyperbaric oxygen: implications for sensitization to seizures in re-exposures.

Authors:  Mikulas Chavko; N Suzan Nadi; David O Keyser
Journal:  Neurochem Res       Date:  2002-12       Impact factor: 3.996

Review 10.  Nitric oxide: mediator, murderer, and medicine.

Authors:  E Anggård
Journal:  Lancet       Date:  1994-05-14       Impact factor: 79.321

View more
  1 in total

1.  Exposure time related oxidative action of hyperbaric oxygen in rat brain.

Authors:  Ahmet Korkmaz; Sükrü Oter; Serdar Sadir; Turgut Topal; Bülent Uysal; Mehmet Ozler; Hakan Ay; Ahmet Akin
Journal:  Neurochem Res       Date:  2007-08-21       Impact factor: 3.996

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.